Silexion Therapeutics ( ($SLXN) ) has provided an update. On May 22, 2025, Silexion Therapeutics Corp, a Cayman Islands exempted company, received ...

Silexion’s new groundbreaking study explores the potential impact of its next generation RNAI therapeutic candidate beyond pancreatic cancer aiming to address critical unmet needs in additional ...

Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotech company developing RNA interference (RNAi) ...

SEATTLE, WA - May 12, 2025 - The KD Hall Foundation, a Washington-based nonprofit advancing leadership, education, and mental health for women and girls, will celebrate 10 years of transformative ...

Significant advancements in preclinical pipeline for SIL204, with groundbreaking data demonstrating efficacy against both ...

Silexion Therapeutics Corp (NASDAQ:SLXN), a biopharmaceutical company with a market capitalization of $10.77 million, announced on ...

This page features the latest news about the Silexion Therapeutics share. SLXN stock touches 52-week low at $0.82 amid market challenges In a turbulent market environment, SLXN stock has reached a ...

Nektar Therapeutics (NASDAQ:NKTR) will release its quarterly earnings report on Thursday, 2025-05-08. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Nektar ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...